A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A legfontosabb adatok
- Hol
- Aurora, Chapel Hill, Columbus, Concord, Dallas, Doral, El Paso, Fort Worth, Hialeah, Hickory, Houston, Irving, Jefferson City, Kansas City, Long Island City, Louisville, McKinney, Memphis, Miami, Morehead City, New Hyde Park, New York, Norfolk, Oklahoma City, Raleigh, Reno, San Antonio, St Louis, Topeka, Tucson és Williamsville (Egyesült Államok)Mind a 33 helyszín megnézése
- Fázis
- 2. fázis
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 75 év között vagy?
Forrás: NCT07018323: ki vehet részt
Helyszínek itt: Egyesült Államok
- Aurora, ColoradoHospital not named in the registryRésztvevőt keres
- Chapel Hill, North CarolinaHospital not named in the registryRésztvevőt keres
- Columbus, GeorgiaHospital not named in the registryRésztvevőt keres
- Concord, CaliforniaHospital not named in the registryRésztvevőt keres
- Dallas, TexasHospital not named in the registryRésztvevőt keres
- Doral, FloridaHospital not named in the registryRésztvevőt keres
- El Paso, TexasHospital not named in the registryRésztvevőt keres
- Fort Worth, TexasHospital not named in the registryRésztvevőt keres
- Hialeah, FloridaHospital not named in the registryRésztvevőt keres
- Hickory, North CarolinaHospital not named in the registryRésztvevőt keres
- Houston, TexasHospital not named in the registryRésztvevőt keres
- Houston, TexasHospital not named in the registryRésztvevőt keres
- Irving, TexasHospital not named in the registryRésztvevőt keres
- Irving, TexasHospital not named in the registryNo longer taking part
- Jefferson City, MissouriHospital not named in the registryRésztvevőt keres
- Kansas City, MissouriHospital not named in the registryRésztvevőt keres
- Long Island City, New YorkHospital not named in the registryRésztvevőt keres
- Louisville, KentuckyHospital not named in the registryRésztvevőt keres
- McKinney, TexasHospital not named in the registryRésztvevőt keres
- Memphis, TennesseeHospital not named in the registryRésztvevőt keres
- Miami, FloridaHospital not named in the registryRésztvevőt keres
- Morehead City, North CarolinaHospital not named in the registryRésztvevőt keres
- New Hyde Park, New YorkHospital not named in the registryRésztvevőt keres
- New YorkHospital not named in the registryNo longer taking part
- Norfolk, VirginiaHospital not named in the registryRésztvevőt keres
- Oklahoma City, OklahomaHospital not named in the registryRésztvevőt keres
- Raleigh, North CarolinaHospital not named in the registryRésztvevőt keres
- Reno, NevadaHospital not named in the registryRésztvevőt keres
- San Antonio, TexasHospital not named in the registryRésztvevőt keres
- St Louis, MissouriHospital not named in the registryRésztvevőt keres
- Topeka, KansasHospital not named in the registryRésztvevőt keres
- Tucson, ArizonaHospital not named in the registryRésztvevőt keres
- Williamsville, New YorkHospital not named in the registryRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Immunovant Sciences GmbH
- Azonosító
- NCT07018323EU 2025-521920-31-00
- A regiszteradat frissítve
- 2026. október 30.
- Eredeti leírás
This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.A teljes eredeti leírásKevesebb
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease
This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.
Bevonási feltételek: Participants with the ability to understand the requirements of the trial, provide written informed consent, and comply with the trial protocol procedures; Male or female participants aged ≥ 18 years; Participants with diagnosis of GD who are hyperthyroid despite ATD treatment; Other, more specific inclusion criteria are defined in the protocol.
Kizáró feltételek: Have previously been successfully treated with radioactive iodine (RAI) therapy or have undergone total thyroidectomy; Have an autoimmune disease other than GD requiring treatment that, in the Investigator's judgment, puts the participant at undue risk; Have moderate-to-severe active thyroid eye disease (TED) and are expected to require immediate surgical intervention and/or are planning corrective surgery/irradiation or medical therapy for TED during study participation; Additional exclusion criteria are defined in the protocol.